Lower Costs, More Cures Act of 2019

3.0.0 801 2022-11-01T18:02:33Z 2022-11-01T18:02:33Z Senate S 2019-03-14 116 ssfi00 Finance Committee Senate Standing Referred to 2019-03-14T14:59:24Z Lower Costs, More Cures Act of 2019 116 19 HR 2019-12-19 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. Related bill CRS Payment Commission Data Act of 2019 116 1264 HR 2019-02-15 Referred to the Subcommittee on Health. Related bill CRS Payment Commission Data Act of 2019 116 1781 HR 2019-10-29 Received in the Senate and Read twice and referred to the Committee on Finance. Related bill CRS Prescription Drug Pricing Reduction Act of 2019 116 2543 S 2019-09-25 Placed on Senate Legislative Calendar under General Orders. Calendar No. 225. Related bill CRS Lower Costs, More Cures Act of 2019 116 3129 S 2019-12-19 Read twice and referred to the Committee on Finance. Related bill CRS Prescription Drug Pricing Reduction Act of 2020 116 4199 S 2020-07-02 Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228) Related bill CRS 2019-03-14 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2019-03-14 Introduced in Senate IntroReferral 10000 9 Library of Congress C001113 Sen. Cortez Masto, Catherine [D-NV] Catherine Cortez Masto D NV N C001056 Sen. Cornyn, John [R-TX] John Cornyn R TX 2019-03-14 True C000174 Sen. Carper, Thomas R. [D-DE] Thomas Carper D DE R. 2019-03-14 True C001075 Sen. Cassidy, Bill [R-LA] Bill Cassidy R LA 2019-03-14 True Health Advisory bodies Health care costs and insurance Health information and medical records Health programs administration and funding Medicaid Medicare Prescription drugs Health

00 2019-03-14 Introduced in Senate 2019-10-29T22:28:40Z This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

]]>

A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. Display Title A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. Official Title as Introduced A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. Introduced in Senate IS Introduced in Senate 2019-03-14T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s801is/xml/BILLS-116s801is.xml 2019-03-14 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.